Xencor, Inc Operating Cash Flow
Xencor, Inc (XNCR) reported Operating Cash Flow of -$123.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Xencor, Inc net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$55.66M.
- Xencor, Inc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$67.63M.
- Xencor, Inc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$51.71M.
- Xencor, Inc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$30.82M.
- Xencor, Inc net cash provided by (used in) operating activities for fiscal 2025 was -$135.12M.
- Xencor, Inc net cash provided by (used in) operating activities for fiscal 2024 was -$202.19M.
- Xencor, Inc net cash provided by (used in) operating activities for fiscal 2023 was -$77.93M, a 418.26% decline from fiscal 2022.
- Xencor, Inc net cash provided by (used in) operating activities for fiscal 2022 was $24.48M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$55.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$123.29M 10-Q · filed 2026-08-05 | -$175.00M derived: sum of 3 quarters · filed 2026-08-05 | -$205.81M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$67.63M 10-Q · filed 2026-05-06 | -$119.34M derived: sum of 2 quarters · filed 2026-05-06 | -$150.16M derived: sum of 3 quarters · filed 2026-05-06 | -$186.53M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$51.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$82.53M derived: sum of 2 quarters · filed 2026-02-25 | -$118.90M derived: sum of 3 quarters · filed 2026-08-05 | -$135.12M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$30.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$67.19M derived: sum of 2 quarters · filed 2026-08-05 | -$83.41M 10-Q · filed 2025-11-05 | -$133.24M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$36.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$52.59M 10-Q · filed 2026-08-05 | -$102.43M derived: sum of 3 quarters · filed 2026-08-05 | -$130.57M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$16.22M 10-Q · filed 2026-05-06 | -$66.06M derived: sum of 2 quarters · filed 2026-05-06 | -$94.20M derived: sum of 3 quarters · filed 2026-05-06 | -$161.55M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$49.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$77.98M derived: sum of 2 quarters · filed 2026-02-25 | -$145.33M derived: sum of 3 quarters · filed 2026-02-25 | -$202.19M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$28.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$95.49M derived: sum of 2 quarters · filed 2025-11-05 | -$152.35M 10-Q · filed 2025-11-05 | -$146.61M 10-Q · filed 2024-11-06 | -$134.18M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | -$67.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$124.21M 10-Q · filed 2025-08-06 | -$120.59M 10-Q · filed 2024-08-05 | -$106.04M derived: sum of 3 quarters · filed 2026-02-25 | -$133.32M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | -$56.86M 10-Q · filed 2025-05-07 | -$55.26M 10-Q · filed 2024-05-09 | -$38.69M derived: sum of 2 quarters · filed 2026-02-25 | -$65.97M derived: sum of 3 quarters · filed 2026-02-25 | -$104.17M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $18.17M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | -$9.11M derived: sum of 2 quarters · filed 2026-02-25 | -$47.31M derived: sum of 3 quarters · filed 2026-02-25 | -$77.93M 10-K · filed 2026-02-25 | $85.11M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$27.28M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | -$65.48M derived: sum of 2 quarters · filed 2025-02-24 | -$96.09M 10-Q/A · filed 2025-02-24 | -$120.53M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$38.20M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-02-24 | -$68.81M 10-Q/A · filed 2025-02-24 | -$93.25M derived: sum of 3 quarters · filed 2025-02-27 | -$94.41M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$30.61M 10-Q/A · filed 2025-02-24 | -$55.05M derived: sum of 2 quarters · filed 2025-02-27 | -$56.21M derived: sum of 3 quarters · filed 2025-02-27 | -$11.94M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$24.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$25.60M derived: sum of 2 quarters · filed 2025-02-27 | $18.67M derived: sum of 3 quarters · filed 2025-02-27 | $24.48M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $43.10M derived: sum of 2 quarters · filed 2023-11-08 | $48.92M 10-Q · filed 2023-11-08 | $110.71M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-06-30 | $44.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $50.08M 10-Q · filed 2023-08-03 | $111.87M derived: sum of 3 quarters · filed 2025-02-24 | $72.85M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-03-31 | $5.82M 10-Q · filed 2023-05-08 | $67.61M derived: sum of 2 quarters · filed 2025-02-24 | $28.58M derived: sum of 3 quarters · filed 2025-02-24 | $18.93M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2021-12-31 | $61.79M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $22.77M derived: sum of 2 quarters · filed 2025-02-24 | $13.11M derived: sum of 3 quarters · filed 2025-02-24 | -$16.85M 10-K/A · filed 2025-02-24 | ||||
| 2021-09-30 | -$39.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$48.68M derived: sum of 2 quarters · filed 2022-11-07 | -$78.64M 10-Q · filed 2022-11-07 | -$61.56M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$9.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$39.62M 10-Q · filed 2022-08-03 | -$22.54M derived: sum of 3 quarters · filed 2023-02-27 | -$26.40M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$29.97M 10-Q · filed 2022-05-05 | -$12.88M derived: sum of 2 quarters · filed 2023-02-27 | -$16.75M derived: sum of 3 quarters · filed 2023-02-27 | -$44.43M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $17.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $13.22M derived: sum of 2 quarters · filed 2023-02-27 | -$14.46M derived: sum of 3 quarters · filed 2023-02-27 | -$5.00M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | -$3.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$31.55M derived: sum of 2 quarters · filed 2021-11-08 | -$22.09M 10-Q · filed 2021-11-08 | -$41.66M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$27.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$18.22M 10-Q · filed 2021-08-04 | -$37.80M derived: sum of 3 quarters · filed 2022-02-24 | -$44.28M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $9.46M 10-Q · filed 2021-05-05 | -$10.12M derived: sum of 2 quarters · filed 2022-02-24 | -$16.59M derived: sum of 3 quarters · filed 2022-02-24 | $92.56M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$19.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$26.05M derived: sum of 2 quarters · filed 2022-02-24 | $83.10M derived: sum of 3 quarters · filed 2022-02-24 | $64.37M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $102.68M derived: sum of 2 quarters · filed 2020-11-06 | $83.95M 10-Q · filed 2020-11-06 | $67.17M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $109.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $90.43M 10-Q · filed 2020-08-05 | $73.65M derived: sum of 3 quarters · filed 2021-02-24 | $63.34M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$18.73M 10-Q · filed 2020-05-08 | -$35.51M derived: sum of 2 quarters · filed 2021-02-24 | -$45.82M derived: sum of 3 quarters · filed 2021-02-24 | -$74.24M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$16.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$27.09M derived: sum of 2 quarters · filed 2021-02-24 | -$55.51M derived: sum of 3 quarters · filed 2021-02-24 | -$79.76M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$10.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$38.73M derived: sum of 2 quarters · filed 2019-11-05 | -$62.98M 10-Q · filed 2019-11-05 | -$69.64M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$28.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$52.66M 10-Q · filed 2019-08-07 | -$59.33M derived: sum of 3 quarters · filed 2020-02-25 | -$62.84M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$24.25M 10-Q · filed 2019-05-09 | -$30.91M derived: sum of 2 quarters · filed 2020-02-25 | -$34.42M derived: sum of 3 quarters · filed 2020-02-25 | -$47.30M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | -$6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$10.18M derived: sum of 2 quarters · filed 2020-02-25 | -$23.05M derived: sum of 3 quarters · filed 2020-02-25 | -$33.60M 10-K · filed 2020-02-25 | -$33.68M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$16.39M derived: sum of 2 quarters · filed 2018-11-05 | -$26.93M 10-Q · filed 2018-11-05 | -$27.02M 10-Q · filed 2017-11-08 | -$42.10M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$12.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$23.42M 10-Q · filed 2018-08-07 | -$23.51M 10-Q · filed 2017-08-07 | -$38.59M derived: sum of 3 quarters · filed 2019-02-26 | $95.48M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$10.55M 10-Q · filed 2018-05-07 | -$25.71M derived: sum of 2 quarters · filed 2019-02-26 | $108.36M derived: sum of 3 quarters · filed 2019-02-26 | |||||
| 2016-12-31 | -$15.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $118.91M derived: sum of 2 quarters · filed 2019-02-26 | $95.24M 10-K · filed 2019-02-26 | $94.62M 10-K · filed 2018-02-28 | ||||
| 2016-09-30 | $134.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $110.41M 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | -$23.67M 10-Q · filed 2017-08-07 | |||||||
| 2015-12-31 | $26.67M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |